howtosupplement
Inflammation/Hormonal/Weight

Alpha-lipoic acid

Antioxidant cofactor that may ease neuropathy symptoms and modestly improve glucose control in adults with insulin resistance.

Alpha-lipoic acid

Alpha-lipoic acid

58
score
B
evidence
Caution
risk

Proven Benefits

01Reduces neuropathy symptoms
02Improves insulin sensitivity
03Promotes modest weight loss
04May lower fasting glucose/HbA1c
05May lower CRP and IL-6
06May improve endothelial function

Chemical Forms

Recommended
  • Alpha-lipoic acid
  • R-alpha-lipoic acid (stabilized sodium R-lipoate)
Avoid
  • Unstabilized R-alpha-lipoic acid (less stable, potency may degrade)
Expert Note

Most clinical trials used standard ALA, so it remains the evidence-based default. Stabilized R-ALA may produce somewhat higher blood levels, but ordinary R-ALA is less chemically stable; if you choose the R-form, a stabilized salt such as sodium R-lipoate is preferable.

Protocol

Amount
300-600 mg
Frequency
Once daily or split into 2 doses
When
Empty stomach, 30 minutes before meals or 2 hours after food; if nausea occurs, take with a light snack.

Condition-Based Dosing

General metabolic or antioxidant support
300 mg daily
Insulin resistance, prediabetes, or overweight adults
300-600 mg daily for 8-12 weeks
Neuropathy under clinician supervision
600 mg daily for 4-12 weeks

Safety & Limits

Upper Safe Limit
No official UL; up to 1200 mg/day has been studied short term, but 600 mg/day is a prudent self-care ceiling.
Cycling
Safe for continuous use

Contraindications

Insulin, sulfonylureas, or other glucose-lowering drugs — may increase hypoglycemia risk
Heavy alcohol use or known thiamine deficiency — correct thiamine first; rare serious reactions reported
Pregnancy or breastfeeding — insufficient safety data for routine use
Planned surgery — may affect perioperative blood glucose; stop 1-2 weeks before unless your clinician advises otherwise
History of insulin autoimmune syndrome — case reports link ALA to autoimmune hypoglycemia, especially in genetically susceptible people

Synergies

Acetyl-L-carnitine

Acetyl-L-carnitine complements ALA at the mitochondrial level and has been studied with it for neuropathic symptoms and nerve function.

Benfotiamine

Benfotiamine targets glucose-driven nerve damage and AGE formation, giving broader coverage in diabetic neuropathy than ALA alone.

Avoid Combining With

  • ✕Food, especially large or high-fat meals (reduces absorption — take away from meals)
  • ✕Iron, magnesium, calcium, or zinc supplements (separate by 2+ hours — possible mineral binding)
  • ✕Alcohol (worsens thiamine depletion and neuropathy risk)
Updated Invalid Date